aluates Reports

$ 0.0

Automative

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-9U12835

Global Drug Safety and Pharmacovigilance Service Market Research Report 2022

BUY CHAPTERS

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Code: QYRE-Auto-9U12835

Report

March 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

BioPoint

PAREXEL

PHARMALEX GMBH

SGS Ltd

Drug Safety Solutions

Hilbrans

Orbis Clinical

ProPharma

SJ Pharma Consulting LLC

Vitrana

X7 Research

CMED

Drug Safety and Pharmacovigilance Service Market Size

The global market for Drug Safety and Pharmacovigilance Service was valued at US$ 46.5 million in the year 2024 and is projected to reach a revised size of US$ 60.2 million by 2031, growing at a CAGR of 3.8% during the forecast period.

Drug Safety and Pharmacovigilance Service Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Safety and Pharmacovigilance Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety and Pharmacovigilance Service.

The Drug Safety and Pharmacovigilance Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Safety and Pharmacovigilance Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Safety and Pharmacovigilance Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Safety and Pharmacovigilance Service Market Report

Report Metric	Details
Report Name	Drug Safety and Pharmacovigilance Service Market
Accounted market size in year	US$ 46.5 million
Forecasted market size in 2031	US$ 60.2 million
CAGR	3.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Drug Safety Service Drug Pharmacovigilance Service
Segment by Application	Experimental Stage Clinical Stage Postmarketing Stage Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioPoint, Cmed, Drug Safety Solutions, Hilbrans, Orbis Clinical, Parexel, PharmaLex, ProPharma, SGS, SJ Pharma Consulting LLC, Vitrana, X7 Research
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Safety and Pharmacovigilance Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Safety and Pharmacovigilance Service Market growing?

Ans: The Drug Safety and Pharmacovigilance Service Market witnessing a CAGR of 3.8% during the forecast period 2025-2031.

What is the Drug Safety and Pharmacovigilance Service Market size in 2031?

Ans: The Drug Safety and Pharmacovigilance Service Market size in 2031 will be US$ 60.2 million.

Who are the main players in the Drug Safety and Pharmacovigilance Service Market report?

Ans: The main players in the Drug Safety and Pharmacovigilance Service Market are BioPoint, Cmed, Drug Safety Solutions, Hilbrans, Orbis Clinical, Parexel, PharmaLex, ProPharma, SGS, SJ Pharma Consulting LLC, Vitrana, X7 Research

What are the Application segmentation covered in the Drug Safety and Pharmacovigilance Service Market report?

Ans: The Applications covered in the Drug Safety and Pharmacovigilance Service Market report are Experimental Stage, Clinical Stage, Postmarketing Stage, Other

What are the Type segmentation covered in the Drug Safety and Pharmacovigilance Service Market report?

Ans: The Types covered in the Drug Safety and Pharmacovigilance Service Market report are Drug Safety Service, Drug Pharmacovigilance Service

Recommended Reports

Drug Testing & Safety

Diagnostics & Monitoring

Drug Development & Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Drug Safety Service

1.2.3 Drug Pharmacovigilance Service

1.3 Market by Application

1.3.1 Global Drug Safety and Pharmacovigilance Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Experimental Stage

1.3.3 Clinical Stage

1.3.4 Postmarketing Stage

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Safety and Pharmacovigilance Service Market Perspective (2020-2031)

2.2 Global Drug Safety and Pharmacovigilance Service Growth Trends by Region

2.2.1 Global Drug Safety and Pharmacovigilance Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Safety and Pharmacovigilance Service Historic Market Size by Region (2020-2025)

2.2.3 Drug Safety and Pharmacovigilance Service Forecasted Market Size by Region (2026-2031)

2.3 Drug Safety and Pharmacovigilance Service Market Dynamics

2.3.1 Drug Safety and Pharmacovigilance Service Industry Trends

2.3.2 Drug Safety and Pharmacovigilance Service Market Drivers

2.3.3 Drug Safety and Pharmacovigilance Service Market Challenges

2.3.4 Drug Safety and Pharmacovigilance Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Safety and Pharmacovigilance Service Players by Revenue

3.1.1 Global Top Drug Safety and Pharmacovigilance Service Players by Revenue (2020-2025)

3.1.2 Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Players (2020-2025)

3.2 Global Drug Safety and Pharmacovigilance Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Safety and Pharmacovigilance Service Revenue

3.4 Global Drug Safety and Pharmacovigilance Service Market Concentration Ratio

3.4.1 Global Drug Safety and Pharmacovigilance Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Service Revenue in 2024

3.5 Global Key Players of Drug Safety and Pharmacovigilance Service Head office and Area Served

3.6 Global Key Players of Drug Safety and Pharmacovigilance Service, Product and Application

3.7 Global Key Players of Drug Safety and Pharmacovigilance Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Safety and Pharmacovigilance Service Breakdown Data by Type

4.1 Global Drug Safety and Pharmacovigilance Service Historic Market Size by Type (2020-2025)

4.2 Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Type (2026-2031)

5 Drug Safety and Pharmacovigilance Service Breakdown Data by Application

5.1 Global Drug Safety and Pharmacovigilance Service Historic Market Size by Application (2020-2025)

5.2 Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drug Safety and Pharmacovigilance Service Market Size (2020-2031)

6.2 North America Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025)

6.4 North America Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Safety and Pharmacovigilance Service Market Size (2020-2031)

7.2 Europe Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025)

7.4 Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size (2020-2031)

8.2 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Safety and Pharmacovigilance Service Market Size (2020-2031)

9.2 Latin America Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025)

9.4 Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size (2020-2031)

10.2 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioPoint

11.1.1 BioPoint Company Details

11.1.2 BioPoint Business Overview

11.1.3 BioPoint Drug Safety and Pharmacovigilance Service Introduction

11.1.4 BioPoint Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.1.5 BioPoint Recent Development

11.2 Cmed

11.2.1 Cmed Company Details

11.2.2 Cmed Business Overview

11.2.3 Cmed Drug Safety and Pharmacovigilance Service Introduction

11.2.4 Cmed Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.2.5 Cmed Recent Development

11.3 Drug Safety Solutions

11.3.1 Drug Safety Solutions Company Details

11.3.2 Drug Safety Solutions Business Overview

11.3.3 Drug Safety Solutions Drug Safety and Pharmacovigilance Service Introduction

11.3.4 Drug Safety Solutions Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.3.5 Drug Safety Solutions Recent Development

11.4 Hilbrans

11.4.1 Hilbrans Company Details

11.4.2 Hilbrans Business Overview

11.4.3 Hilbrans Drug Safety and Pharmacovigilance Service Introduction

11.4.4 Hilbrans Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.4.5 Hilbrans Recent Development

11.5 Orbis Clinical

11.5.1 Orbis Clinical Company Details

11.5.2 Orbis Clinical Business Overview

11.5.3 Orbis Clinical Drug Safety and Pharmacovigilance Service Introduction

11.5.4 Orbis Clinical Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.5.5 Orbis Clinical Recent Development

11.6 Parexel

11.6.1 Parexel Company Details

11.6.2 Parexel Business Overview

11.6.3 Parexel Drug Safety and Pharmacovigilance Service Introduction

11.6.4 Parexel Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.6.5 Parexel Recent Development

11.7 PharmaLex

11.7.1 PharmaLex Company Details

11.7.2 PharmaLex Business Overview

11.7.3 PharmaLex Drug Safety and Pharmacovigilance Service Introduction

11.7.4 PharmaLex Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.7.5 PharmaLex Recent Development

11.8 ProPharma

11.8.1 ProPharma Company Details

11.8.2 ProPharma Business Overview

11.8.3 ProPharma Drug Safety and Pharmacovigilance Service Introduction

11.8.4 ProPharma Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.8.5 ProPharma Recent Development

11.9 SGS

11.9.1 SGS Company Details

11.9.2 SGS Business Overview

11.9.3 SGS Drug Safety and Pharmacovigilance Service Introduction

11.9.4 SGS Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.9.5 SGS Recent Development

11.10 SJ Pharma Consulting LLC

11.10.1 SJ Pharma Consulting LLC Company Details

11.10.2 SJ Pharma Consulting LLC Business Overview

11.10.3 SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Introduction

11.10.4 SJ Pharma Consulting LLC Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.10.5 SJ Pharma Consulting LLC Recent Development

11.11 Vitrana

11.11.1 Vitrana Company Details

11.11.2 Vitrana Business Overview

11.11.3 Vitrana Drug Safety and Pharmacovigilance Service Introduction

11.11.4 Vitrana Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.11.5 Vitrana Recent Development

11.12 X7 Research

11.12.1 X7 Research Company Details

11.12.2 X7 Research Business Overview

11.12.3 X7 Research Drug Safety and Pharmacovigilance Service Introduction

11.12.4 X7 Research Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025)

11.12.5 X7 Research Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

BioPoint

PAREXEL

PHARMALEX GMBH

SGS Ltd

Drug Safety Solutions

Hilbrans

Orbis Clinical

ProPharma

SJ Pharma Consulting LLC

Vitrana

X7 Research

CMED

List of Tables

Table 1. Global Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Drug Safety Service

Table 3. Key Players of Drug Pharmacovigilance Service

Table 4. Global Drug Safety and Pharmacovigilance Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Drug Safety and Pharmacovigilance Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Drug Safety and Pharmacovigilance Service Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Drug Safety and Pharmacovigilance Service Market Share by Region (2020-2025)

Table 8. Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Drug Safety and Pharmacovigilance Service Market Share by Region (2026-2031)

Table 10. Drug Safety and Pharmacovigilance Service Market Trends

Table 11. Drug Safety and Pharmacovigilance Service Market Drivers

Table 12. Drug Safety and Pharmacovigilance Service Market Challenges

Table 13. Drug Safety and Pharmacovigilance Service Market Restraints

Table 14. Global Drug Safety and Pharmacovigilance Service Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Drug Safety and Pharmacovigilance Service Market Share by Players (2020-2025)

Table 16. Global Top Drug Safety and Pharmacovigilance Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance Service as of 2024)

Table 17. Ranking of Global Top Drug Safety and Pharmacovigilance Service Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Drug Safety and Pharmacovigilance Service Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Drug Safety and Pharmacovigilance Service, Headquarters and Area Served

Table 20. Global Key Players of Drug Safety and Pharmacovigilance Service, Product and Application

Table 21. Global Key Players of Drug Safety and Pharmacovigilance Service, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Drug Safety and Pharmacovigilance Service Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Type (2020-2025)

Table 25. Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Type (2026-2031)

Table 27. Global Drug Safety and Pharmacovigilance Service Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Application (2020-2025)

Table 29. Global Drug Safety and Pharmacovigilance Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Drug Safety and Pharmacovigilance Service Revenue Market Share by Application (2026-2031)

Table 31. North America Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size by Country (2026-2031) & (US$ Million)

Table 46. BioPoint Company Details

Table 47. BioPoint Business Overview

Table 48. BioPoint Drug Safety and Pharmacovigilance Service Product

Table 49. BioPoint Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 50. BioPoint Recent Development

Table 51. Cmed Company Details

Table 52. Cmed Business Overview

Table 53. Cmed Drug Safety and Pharmacovigilance Service Product

Table 54. Cmed Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 55. Cmed Recent Development

Table 56. Drug Safety Solutions Company Details

Table 57. Drug Safety Solutions Business Overview

Table 58. Drug Safety Solutions Drug Safety and Pharmacovigilance Service Product

Table 59. Drug Safety Solutions Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 60. Drug Safety Solutions Recent Development

Table 61. Hilbrans Company Details

Table 62. Hilbrans Business Overview

Table 63. Hilbrans Drug Safety and Pharmacovigilance Service Product

Table 64. Hilbrans Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 65. Hilbrans Recent Development

Table 66. Orbis Clinical Company Details

Table 67. Orbis Clinical Business Overview

Table 68. Orbis Clinical Drug Safety and Pharmacovigilance Service Product

Table 69. Orbis Clinical Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 70. Orbis Clinical Recent Development

Table 71. Parexel Company Details

Table 72. Parexel Business Overview

Table 73. Parexel Drug Safety and Pharmacovigilance Service Product

Table 74. Parexel Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 75. Parexel Recent Development

Table 76. PharmaLex Company Details

Table 77. PharmaLex Business Overview

Table 78. PharmaLex Drug Safety and Pharmacovigilance Service Product

Table 79. PharmaLex Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 80. PharmaLex Recent Development

Table 81. ProPharma Company Details

Table 82. ProPharma Business Overview

Table 83. ProPharma Drug Safety and Pharmacovigilance Service Product

Table 84. ProPharma Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 85. ProPharma Recent Development

Table 86. SGS Company Details

Table 87. SGS Business Overview

Table 88. SGS Drug Safety and Pharmacovigilance Service Product

Table 89. SGS Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 90. SGS Recent Development

Table 91. SJ Pharma Consulting LLC Company Details

Table 92. SJ Pharma Consulting LLC Business Overview

Table 93. SJ Pharma Consulting LLC Drug Safety and Pharmacovigilance Service Product

Table 94. SJ Pharma Consulting LLC Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 95. SJ Pharma Consulting LLC Recent Development

Table 96. Vitrana Company Details

Table 97. Vitrana Business Overview

Table 98. Vitrana Drug Safety and Pharmacovigilance Service Product

Table 99. Vitrana Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 100. Vitrana Recent Development

Table 101. X7 Research Company Details

Table 102. X7 Research Business Overview

Table 103. X7 Research Drug Safety and Pharmacovigilance Service Product

Table 104. X7 Research Revenue in Drug Safety and Pharmacovigilance Service Business (2020-2025) & (US$ Million)

Table 105. X7 Research Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Drug Safety and Pharmacovigilance Service Picture

Figure 2. Global Drug Safety and Pharmacovigilance Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Safety and Pharmacovigilance Service Market Share by Type: 2024 VS 2031

Figure 4. Drug Safety Service Features

Figure 5. Drug Pharmacovigilance Service Features

Figure 6. Global Drug Safety and Pharmacovigilance Service Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Drug Safety and Pharmacovigilance Service Market Share by Application: 2024 VS 2031

Figure 8. Experimental Stage Case Studies

Figure 9. Clinical Stage Case Studies

Figure 10. Postmarketing Stage Case Studies

Figure 11. Other Case Studies

Figure 12. Drug Safety and Pharmacovigilance Service Report Years Considered

Figure 13. Global Drug Safety and Pharmacovigilance Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Drug Safety and Pharmacovigilance Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Drug Safety and Pharmacovigilance Service Market Share by Region: 2024 VS 2031

Figure 16. Global Drug Safety and Pharmacovigilance Service Market Share by Players in 2024

Figure 17. Global Top Drug Safety and Pharmacovigilance Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Safety and Pharmacovigilance Service as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Drug Safety and Pharmacovigilance Service Revenue in 2024

Figure 19. North America Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Drug Safety and Pharmacovigilance Service Market Share by Country (2020-2031)

Figure 21. United States Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Drug Safety and Pharmacovigilance Service Market Share by Country (2020-2031)

Figure 25. Germany Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Drug Safety and Pharmacovigilance Service Market Share by Region (2020-2031)

Figure 33. China Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Drug Safety and Pharmacovigilance Service Market Share by Country (2020-2031)

Figure 41. Mexico Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Drug Safety and Pharmacovigilance Service Market Share by Country (2020-2031)

Figure 45. Turkey Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Drug Safety and Pharmacovigilance Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. BioPoint Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 49. Cmed Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 50. Drug Safety Solutions Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 51. Hilbrans Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 52. Orbis Clinical Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 53. Parexel Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 54. PharmaLex Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 55. ProPharma Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 56. SGS Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 57. SJ Pharma Consulting LLC Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 58. Vitrana Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 59. X7 Research Revenue Growth Rate in Drug Safety and Pharmacovigilance Service Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pharmaceutical Compliance Service Market Research Report 2025

Global Drug Stability Testing Services Market Research Report 2025

Global Still s Disease Treatment Market Research Report 2025

Global Road Side Drug Testing Service Market Research Report 2025

Global Pharma Contract Service Market Research Report 2025

Global Drugs of Abuse Testing Market Research Report 2024

Global Diagnostic Guidewire Market Research Report 2024

Global Pharmerging Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Global Pharmaceutical Asset Management Market Research Report 2025

Global Pill Organizer with Timer Reminder Market Research Report 2025

Global Weekly Pill Organizer Market Research Report 2025

Global Anti Infectives Market Research Report 2025

Global Coding and Marking for Pharmaceuticals and Consumer Products Market Research Report 2024

Drug Screening Test Kit Market

Global Combination Therapy Drug Market Research Report 2025

Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

Global Pharmaceutical Stability Storage Service Market Research Report 2025

Global Pharmacovigilance Services Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions